Ulcerative colitis. Ulcerative colitis
Conditions
Interventions
Intervention 1: Traditional product in intervention group including: Boswellia serrata (2 parts), Punica granatum (1 parts), Terminalia chebula (1 parts) and curcuma lunga (2 parts) has been confirmed
Treatment - Drugs
Traditional product in intervention group including: Boswellia serrata (2 parts), Punica granatum (1 parts), Terminalia chebula (1 parts) and curcuma lunga (2 parts) has been confirmed in Medicinal pl
Routine treatment in control group including Sulfasalazine Tab 500 mg, 6 tab in a day
Sponsors
Vice chancellor for research, Mashahd University of Medical Sciences And Golestan Research Center of
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Diagnosis of ulcerative colitis by a gastroentrologist; disease activity index of 5 or more; no need to hospital admission at the inclusion time Exclusion criteria: No consent to enter the study or continuing it; gastrointestinal complications (dyspepsia, abdominal pain in epigastric area); smoking cigars
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease activity index. Timepoint: Including into the study, 4 weeks after intervention. Method of measurement: Self-administrative questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptoms of Ulcerative colitis. Timepoint: Inclusion time- 4 weeks after the intervention. Method of measurement: self-administrative questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Hamidreza Rostamani
Mashahd University of Medical Scineces
Outcome results
None listed